Pharmasecure Inc. – Trademark Portfolio
Entity Type: 03
Pharmasecure Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 6 filings in this category. The portfolio also extends into Class 38 (Telecommunications) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include PSID and PHARMASECURE. The owner is based in Lebanon, NH.
16 Cavendish Court
Lebanon, NH 03766
Showing of trademarks Trademarks
Trademark Classifications
Pharmasecure Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Pharmasecure Inc. have?
Pharmasecure Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned, 1 cancelled.
What trademark classes does Pharmasecure Inc. file in?
Pharmasecure Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Pharmasecure Inc.'s most well-known trademarks?
Pharmasecure Inc.'s registered trademark portfolio includes well-known marks such as PSID and PHARMASECURE. These are among 2 currently registered trademarks in the portfolio.
What is Pharmasecure Inc.'s trademark registration success rate?
Pharmasecure Inc. has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.